Mucuna pruriens for Health & Longevity - Quick Reference Sheet
evipedia.ai
← Back

Mucuna pruriens for Health & Longevity

Created on 08/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Seeds carry the same active substance as prescription Parkinson's treatment, sometimes above a pharmacy tablet. Strongest evidence is movement disorders, where roasted seed powder matched or outperformed standard preparations. Fertility and stress findings come from one research group without a placebo. Nausea leads people to stop; raw seeds have caused hallucination; labels are unreliable. Nothing measured past twelve months. (Full Review)

Protocol

Whole roasted seed powder (the trial-validated form)
12.5 to 17.5 mg/kg body weight per dose
15 to 30 g per dose in the earliest trials. The only form with randomised human evidence.
Split versus single dose
Split
Two or three smaller doses match the short half-life, cut peak-driven nausea and reduce pulsatile exposure.
Best time of day
Morning and early afternoon
Dopaminergic activation late in the day fragments sleep; the second dose is best taken before 4 p.m.
Time to effect
Motor and alertness effects
30 to 90 minutes
After a single dose.
Hormonal and semen changes
Three months
Semen needs a full production cycle.
Cortisol and state anxiety
Three months
Measured only in stressed subfertile men, with no placebo group.

Benefits

Contraindications
  • Pregnancy and breastfeeding, at any dose
  • Diagnosed psychotic illness, bipolar disorder, or a history of dopamine-related impulse-control disorder
  • Active melanoma or a history of melanoma
  • Narrow-angle glaucoma
  • Active peptic ulcer disease
  • Severe hepatic impairment (Child-Pugh Class C) or advanced kidney disease (filtration below 30 mL/min/1.73 m²)
  • Recent myocardial infarction (within 90 days) or unstable arrhythmia
  • Prescribed levodopa products (levodopa/carbidopa, levodopa/benserazide) outside neurologist supervision
  • Non-selective monoamine oxidase inhibitors (phenelzine, tranylcypromine, isocarboxazid)
Key Interactions
  • Selective monoamine oxidase B inhibitors (selegiline, rasagiline)
  • Dopamine antagonists (haloperidol, risperidone, metoclopramide, prochlorperazine)
  • Antihypertensives and nitrates (amlodipine, lisinopril, isosorbide)
  • Glucose-lowering drugs (metformin, glipizide, insulin)
  • Iron and mineral supplements (ferrous sulfate, calcium, magnesium)
  • Over-the-counter pyridoxine (vitamin B6) and multivitamins containing it
  • Over-the-counter antihistamines and sedating cold remedies (diphenhydramine, doxylamine)
  • Supplements with additive dopaminergic or stimulant effect (L-tyrosine, phenylethylamine, yohimbine, high-dose caffeine)
  • Supplements with additive blood-pressure or glucose lowering (berberine, chromium, hibiscus, garlic extract, magnesium)
  • 5-HTP and serotonergic supplements
  • High-protein meals and ketogenic patterns
    •

Risk & Side Effects

  • High: Dopaminergic nausea, vomiting and appetite loss; unpredictable and mislabelled levodopa content; severe contact itching from pods and spicules
  • Medium: Dyskinesia and dopamine dysregulation with unsupervised long-term use; acute confusion, hallucination and psychosis after raw or poorly prepared seeds
  • Low: Orthostatic blood pressure drop; antinutrient load of under-processed seed; raised homocysteine with sustained daily use
  • Speculative: Long-term motor complications from levodopa monotherapy; melanoma signal carried over from levodopa

Monitoring

Marker Target Why
Prolactin Men below 10 ng/mL; non-pregnant women below 15 ng/mL Most direct peripheral readout of dopamine activity
Total and free testosterone Total 600–900 ng/dL; free 15–25 pg/mL in men Tracks the reproductive claim directly
Semen analysis: concentration, motility, morphology Concentration above 40 million/mL; total motility above 50% The only direct endpoint for fertility use
Morning cortisol 10–15 µg/dL at 8 a.m. Baseline and follow-up for the stress claim
Fasting glucose and glycated haemoglobin Glucose 75–86 mg/dL; glycated haemoglobin 4.8–5.2% Seed extract lowers glucose in animals, so this catches an interaction
Seated and standing blood pressure Below 120/80 mmHg seated; fall under 20/10 mmHg on standing Catches dopaminergic orthostatic drops early
Metabolic panel and complete blood count Within laboratory reference range Screens for organ effects during chronic use
Homocysteine Below 9 µmol/L Levodopa methylation consumes methyl groups and drives it up

Cadence: Blood pressure and symptom review at two weeks; prolactin, testosterone and cortisol at eight to twelve weeks; semen analysis at three months; then every six to twelve months for anyone continuing daily use. Any dose increase or change of product batch resets the two-week check.

Qualitative Assessment

  • Morning drive and task initiation in the first two hours after a dose
  • Presence, timing and depth of an afternoon or evening slump
  • Sleep onset latency and night-time awakenings, tracked against dose timing
  • Nausea, appetite change and early satiety as the leading intolerance signal
  • Libido and, in men, refractory period, the clearest prolactin-linked subjective marker
  • Any new involuntary movement, restlessness or compulsive behaviour, which is a stop signal rather than a trend to track
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.